HTA67 Assessing Relationships Between the Canadian Agency for Drugs and Technologies in Health (CADTH) Revised ICERs and Unmet Need, Clinical Benefit, Price Reductions, and Listing Negotiation Timelines
Abstract
Authors
C Balijepalli J Li S Ferrazzi E Mathers L Gullapalli A Awan